Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors.

Quartuccio L, Bond M, Isola M, Monti S, Felicetti M, Furini F, Murgia S, Berti A, Silvestri E, Pazzola G, Bozzolo E, Leccese P, Raffeiner B, Parisi S, Leccese I, Cianci F, Bettio S, Sainaghi P, Ianniello A, Ravagnani V, Bellando Randone S, Faggioli P, Lomater C, Stobbione P, Ferro F, Colaci M, Alfieri G, Carubbi F, Erre GL, Giollo A, Franzolini N, Ditto MC, Balduzzi S, Padoan R, Bortolotti R, Bortoluzzi A, Cariddi A, Padula A, Di Scala G, Gremese E, Conti F, D'Angelo S, Matucci Cerinic M, Dagna L, Emmi G, Salvarani C, Paolazzi G, Roccatello D, Govoni M, Schiavon F, Caporali R, De Vita S; Italian Study Group on Lung Involvement in Rheumatic Diseases and the Italian Vasculitis Study Group.

J Autoimmun. 2020 Jan 8:102397. doi: 10.1016/j.jaut.2019.102397. [Epub ahead of print]

PMID:
31926833
2.

Sensory block in Day Surgery.

Messineo D, Izzo P, Di Cello PF, Testa SS, Di Scala G, Izzo L, Monti A, Marzio G.

Ann Ital Chir. 2019 Dec 13;8. pii: S0003469X19031476. [Epub ahead of print]

PMID:
31841121
3.

Learning-driven cerebellar intrinsic functional connectivity changes in men.

Edde M, Di Scala G, Dupuy M, Dilharreguy B, Catheline G, Chanraud S.

J Neurosci Res. 2019 Nov 24. doi: 10.1002/jnr.24555. [Epub ahead of print]

PMID:
31762075
4.

Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Ruscitti P, Cipriani P, Liakouli V, Iacono D, Pantano I, Margiotta DPE, Navarini L, Destro Castaniti GM, Maruotti N, Di Scala G, Picciariello L, Caso F, Bongiovanni S, Grembiale RD, Atzeni F, Scarpa R, Perosa F, Emmi G, Cantatore FP, Guggino G, Afeltra A, Ciccia F, Giacomelli R.

Arthritis Res Ther. 2019 Sep 3;21(1):204. doi: 10.1186/s13075-019-1975-y.

5.

Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease.

Lopalco G, Venerito V, Leccese P, Emmi G, Cantarini L, Lascaro N, Di Scala G, Fabiani C, Rigante D, Iannone F.

Ann Rheum Dis. 2019 Dec;78(12):1736-1737. doi: 10.1136/annrheumdis-2019-215437. Epub 2019 Aug 10. No abstract available.

PMID:
31401548
6.

Intravenous immunoglobulin therapy: a snapshot for the internist.

Vitiello G, Emmi G, Silvestri E, Di Scala G, Palterer B, Parronchi P.

Intern Emerg Med. 2019 Oct;14(7):1041-1049. doi: 10.1007/s11739-019-02150-z. Epub 2019 Jul 15. Review.

PMID:
31309519
7.

Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.

Lopalco G, Venerito V, Cantarini L, Emmi G, Salaffi F, Di Carlo M, Tafuri S, Gentileschi S, Di Scala G, Nivuori M, Cacciapaglia F, Galeazzi M, Lapadula G, Iannone F.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):762-767. Epub 2019 Apr 16.

PMID:
31025925
8.

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study.

Bitossi A, Bettiol A, Silvestri E, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Prisco D, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Emmi G.

Mediators Inflamm. 2019 Feb 10;2019:1623847. doi: 10.1155/2019/1623847. eCollection 2019.

9.

The right place of interleukin-1 inhibitors in the treatment of Behçet's syndrome: a systematic review.

Bettiol A, Silvestri E, Di Scala G, Amedei A, Becatti M, Fiorillo C, Lopalco G, Salvarani C, Cantarini L, Soriano A, Emmi G.

Rheumatol Int. 2019 Jun;39(6):971-990. doi: 10.1007/s00296-019-04259-y. Epub 2019 Feb 25.

PMID:
30799530
10.

Efficiency of Sensorimotor Networks: Posture and Gait in Young and Older Adults.

Di Scala G, Dupuy M, Guillaud E, Doat E, Barse E, Dillhareguy B, Jean FAM, Audiffren M, Cazalets JR, Chanraud S.

Exp Aging Res. 2019 Jan-Feb;45(1):41-56. doi: 10.1080/0361073X.2018.1560108. Epub 2019 Jan 11.

PMID:
30633644
11.

Vascular Behçet's syndrome: an update.

Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C, Prisco D.

Intern Emerg Med. 2019 Aug;14(5):645-652. doi: 10.1007/s11739-018-1991-y. Epub 2018 Nov 29. Review.

PMID:
30499073
12.

Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects.

Becatti M, Emmi G, Bettiol A, Silvestri E, Di Scala G, Taddei N, Prisco D, Fiorillo C.

Clin Exp Immunol. 2019 Mar;195(3):322-333. doi: 10.1111/cei.13243. Epub 2018 Dec 18. Review.

PMID:
30472725
13.

Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study.

Di Minno MND, Emmi G, Ambrosino P, Scalera A, Tufano A, Cafaro G, Peluso R, Bettiol A, Di Scala G, Silvestri E, Prisco D.

Int J Cardiol. 2019 Jan 1;274:1-6. doi: 10.1016/j.ijcard.2018.06.010. Epub 2018 Jun 5.

PMID:
30454720
14.

Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial.

Rossi GM, Mannoni A, Di Scala G, Silvestri E, Cojan RD, Vannozzi L, Bettiol A, Vaglio A, Emmi G.

Autoimmun Rev. 2018 Dec;17(12):1265-1267. doi: 10.1016/j.autrev.2018.07.004. Epub 2018 Oct 12. No abstract available.

PMID:
30316991
15.

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.

Vitale A, Emmi G, Lopalco G, Fabiani C, Gentileschi S, Silvestri E, Di Scala G, Iannone F, Frediani B, Galeazzi M, Lapadula G, Rigante D, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):267. doi: 10.1007/s10067-018-4302-0.

PMID:
30242638
16.

Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies.

Di Minno MND, Emmi G, Ambrosino P, Scalera A, Tufano A, Cafaro G, Peluso R, Bettiol A, Di Scala G, Silvestri E, Prisco D.

Data Brief. 2018 Jun 27;19:1799-1803. doi: 10.1016/j.dib.2018.06.083. eCollection 2018 Aug.

17.

Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study.

Di Scala G, Bettiol A, Cojan RD, Finocchi M, Silvestri E, Emmi G.

J Autoimmun. 2019 Feb;97:108-113. doi: 10.1016/j.jaut.2018.09.002. Epub 2018 Sep 11.

PMID:
30213443
18.

Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role.

Prisco D, Silvestri E, Di Scala G, Emmi G.

Rheumatology (Oxford). 2019 Apr 1;58(4):563-564. doi: 10.1093/rheumatology/key279. No abstract available.

PMID:
30202974
19.

The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Di Scala G, Sota J, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2018 Aug 27:1-7. doi: 10.1080/09273948.2018.1511810. [Epub ahead of print]

PMID:
30148652
20.

Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.

Gentileschi S, Vitale A, Rigante D, Lopalco G, Emmi G, Orlando I, Di Scala G, Sota J, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Iannone F, Cantarini L.

Isr Med Assoc J. 2018 Jul;20(7):438-441.

21.

A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis.

Martorana D, Márquez A, Carmona FD, Bonatti F, Adorni A, Urban ML, Maritati F, Accorsi Buttini E, Marvisi C, Palmisano A, Rossi GM, Trivioli G, Fenaroli P, Manenti L, Nicastro M, Incerti M, Gianfreda D, Bani S, Ferretti S, Corradi D, Alberici F, Emmi G, Di Scala G, Moroni G, Percesepe A, Scheel PJ Jr, Vermeer E, van Bommel EF, Martín J, Vaglio A.

J Allergy Clin Immunol. 2018 Nov;142(5):1662-1665. doi: 10.1016/j.jaci.2018.06.045. Epub 2018 Aug 4. No abstract available.

PMID:
30081155
22.

Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement.

Emmi G, Vitale A, Silvestri E, Boddi M, Becatti M, Fiorillo C, Fabiani C, Frediani B, Emmi L, Di Scala G, Goldoni M, Bettiol A, Vaglio A, Cantarini L, Prisco D.

Arthritis Rheumatol. 2018 Sep;70(9):1500-1507. doi: 10.1002/art.40531. Epub 2018 Jul 19.

23.

Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, di Scala G, Guerriero S, Orlando I, Franceschini R, Capozzoli M, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Rheumatol. 2018 Jun;37(6):1715-1720. doi: 10.1007/s10067-018-4092-4. Epub 2018 Apr 18.

PMID:
29671190
24.

Brain structural investigation and hippocampal tractography in medication overuse headache: a native space analysis.

Meyer M, Di Scala G, Edde M, Dilharreguy B, Radat F, Allard M, Chanraud S.

Behav Brain Funct. 2017 Apr 8;13(1):6. doi: 10.1186/s12993-017-0124-5.

25.

Brain functional connectivity and morphology changes in medication-overuse headache: Clue for dependence-related processes?

Chanraud S, Di Scala G, Dilharreguy B, Schoenen J, Allard M, Radat F.

Cephalalgia. 2014 Jul;34(8):605-15. doi: 10.1177/0333102413519514. Epub 2014 Jan 21.

26.

Psychological and neuropsychological correlates of dependence-related behaviour in medication overuse headaches: a one year follow-up study.

Radat F, Chanraud S, Di Scala G, Dousset V, Allard M.

J Headache Pain. 2013 Jul 4;14:59. doi: 10.1186/1129-2377-14-59.

27.

Parallel maturation of goal-directed behavior and dopaminergic systems during adolescence.

Naneix F, Marchand AR, Di Scala G, Pape JR, Coutureau E.

J Neurosci. 2012 Nov 14;32(46):16223-32. doi: 10.1523/JNEUROSCI.3080-12.2012.

28.

Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells.

De Bellis A, Sinisi AA, Pane E, Dello Iacovo A, Bellastella G, Di Scala G, Falorni A, Giavoli C, Gasco V, Giordano R, Ambrosio MR, Colao A, Bizzarro A, Bellastella A; Italian Autoimmune Hypophysitis Network Group.

J Clin Endocrinol Metab. 2012 Oct;97(10):3684-90. doi: 10.1210/jc.2012-2269. Epub 2012 Aug 1.

29.

The role of the rat medial prefrontal cortex in adapting to changes in instrumental contingency.

Coutureau E, Esclassan F, Di Scala G, Marchand AR.

PLoS One. 2012;7(4):e33302. doi: 10.1371/journal.pone.0033302. Epub 2012 Apr 4.

30.

Selective hypersensitivity with positive immediate skin tests to nimesulide.

Astarita C, Savoia A, Sepe C, Ivo AM, Di Scala G.

J Investig Allergol Clin Immunol. 2011;21(5):415-6. No abstract available.

31.

Retrospective revaluation and its neural circuit in rats.

San-Galli A, Marchand AR, Decorte L, Di Scala G.

Behav Brain Res. 2011 Oct 1;223(2):262-70. doi: 10.1016/j.bbr.2011.04.024. Epub 2011 Apr 22.

PMID:
21539862
32.

Transient role of the rat prelimbic cortex in goal-directed behaviour.

Tran-Tu-Yen DA, Marchand AR, Pape JR, Di Scala G, Coutureau E.

Eur J Neurosci. 2009 Aug;30(3):464-71. doi: 10.1111/j.1460-9568.2009.06834.x. Epub 2009 Jul 15.

PMID:
19614748
33.

A cholinergic-dependent role for the entorhinal cortex in trace fear conditioning.

Esclassan F, Coutureau E, Di Scala G, Marchand AR.

J Neurosci. 2009 Jun 24;29(25):8087-93. doi: 10.1523/JNEUROSCI.0543-09.2009.

34.

A role for medial prefrontal dopaminergic innervation in instrumental conditioning.

Naneix F, Marchand AR, Di Scala G, Pape JR, Coutureau E.

J Neurosci. 2009 May 20;29(20):6599-606. doi: 10.1523/JNEUROSCI.1234-09.2009.

35.

Entorhinal cortex and cognition.

Coutureau E, Di Scala G.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):753-61. doi: 10.1016/j.pnpbp.2009.03.038. Epub 2009 Apr 17. Review.

PMID:
19376185
36.

Goal-directed responding is sensitive to lesions to the prelimbic cortex or basolateral nucleus of the amygdala but not to their disconnection.

Coutureau E, Marchand AR, Di Scala G.

Behav Neurosci. 2009 Apr;123(2):443-8. doi: 10.1037/a0014818.

PMID:
19331467
37.

Differential contribution of dorsal and ventral hippocampus to trace and delay fear conditioning.

Esclassan F, Coutureau E, Di Scala G, Marchand AR.

Hippocampus. 2009 Jan;19(1):33-44. doi: 10.1002/hipo.20473.

PMID:
18683846
38.

Evidence for a critical role of entorhinal cortex at pre-exposure for latent inhibition disruption in rats.

Seillier A, Dieu Y, Herbeaux K, Di Scala G, Will B, Majchrzak M.

Hippocampus. 2007;17(3):220-6.

PMID:
17203462
39.

Odor increases [3H]phorbol dibutyrate binding to protein kinase C in olfactory structures of rat brain. Effect of entorhinal cortex lesion.

Faillace MP, Zwiller J, Di Scala G, Bernabeu R.

Brain Res. 2006 Jan 12;1068(1):16-22. Epub 2006 Jan 4.

PMID:
16386712
40.

Lesion of the lateral entorhinal cortex amplifies odor-induced expression of c-fos, junB, and zif 268 mRNA in rat brain.

Bernabeu R, Thiriet N, Zwiller J, Di Scala G.

Synapse. 2006 Mar 1;59(3):135-43.

PMID:
16342059
41.

Entorhinal cortex stimulation modulates amygdala and piriform cortex responses to olfactory bulb inputs in the rat.

Mouly AM, Di Scala G.

Neuroscience. 2006;137(4):1131-41. Epub 2005 Dec 1.

PMID:
16325349
42.

Aversive effects elicited by electrical stimulation of the inferior colliculus in normal and audiogenic seizure susceptible rats.

Bagri A, Sandner G, Di Scala G.

Neurosci Lett. 2005 May 13;379(3):180-4. Epub 2005 Jan 28.

PMID:
15843059
43.

Systemic or intra-accumbens injection of D-amphetamine delays habituation to a tone stimulus in rats.

Dieu Y, Seillier A, Majchrzak M, Marchand A, Di Scala G.

Behav Pharmacol. 2005 Feb;16(1):35-42.

PMID:
15706136
44.

Trace fear conditioning: a role for context?

Marchand AR, Luck D, Di Scala G.

Arch Ital Biol. 2004 May;142(3):251-63. Review.

PMID:
15260379
45.

Bilateral lesions of the entorhinal cortex differentially modify haloperidol- and olanzapine-induced c-fos mRNA expression in the rat forebrain.

Seillier A, Coutureau E, Thiriet N, Herbeaux K, Zwiller J, Di Scala G, Will B, Majchrzak M.

Neuropharmacology. 2003 Aug;45(2):190-200.

PMID:
12842125
46.

The entorhinal cortex-nucleus accumbens pathway and latent inhibition: a behavioral and neurochemical study in rats.

Coutureau E, Léna I, Daugé V, Di Scala G.

Behav Neurosci. 2002 Feb;116(1):95-104.

PMID:
11895187
47.
48.

Restoration of latent inhibition by olanzapine but not haloperidol in entorhinal cortex-lesioned rats.

Coutureau E, Gosselin O, Di Scala G.

Psychopharmacology (Berl). 2000 Jun;150(2):226-32.

PMID:
10907677
49.

GABA and muscimol as reversible inactivation tools in learning and memory.

Majchrzak M, Di Scala G.

Neural Plast. 2000;7(1-2):19-29. Review.

50.

Facilitative effects of EGb 761 on olfactory recognition in young and aged rats.

Wirth S, Stemmelin J, Will B, Christen YVES, Di Scala G.

Pharmacol Biochem Behav. 2000 Feb;65(2):321-6.

PMID:
10672985

Supplemental Content

Loading ...
Support Center